期刊文献+

美托洛尔联合曲美他嗪在不稳定性心绞痛患者中的临床治疗效果及对心功能的效果评估 被引量:4

Clinical efficacy of metoprolol combined with trimetazidine in patients with unstable angina and assessment of cardiac function
下载PDF
导出
摘要 目的探讨美托洛尔联合曲美他嗪对不稳定性心绞痛患者施治后获得的临床效果,并且观察对其心功能产生的影响。方法选择108例不稳定性心绞痛患者作为实验对象;所有不稳定性心绞痛患者通过数字奇偶法展开随机分组;对照组(54例):选择常规疗法完成不稳定性心绞痛患者疾病治疗;观察组(54例):选择常规疗法+美托洛尔+曲美他嗪完成不稳定性心绞痛患者疾病治疗,最终就两组不稳定性心绞痛患者心功能表现、心绞痛疗效以及治疗不良反应表现展开对比。结果与对照组患者心功能表现对比,观察组不稳定性心绞痛患者LVEF水平以及SV水平改善程度显著(P<0.05);观察组患者治疗总有效率为98.15%,对照组为75.93%,观察组高于对照组(P<0.05);两组患者不良反应发生情况比较差异无统计学意义。结论临床合理选择美托洛尔+曲美他嗪药物对不稳定性心绞痛患者施治,于心功能改善以及心绞痛疗效提高两方面可以做出充分保证,并且未呈现出显著用药不良反应现象,从而为不稳定性心绞痛患者病情恢复加以显著促进。 Objective To investigate the clinical effect of metoprolol + trimetazidine on patients with unstable angina pectoris and to observe its influence on cardiac function. Methods A total of 108 patients with unstable angina who were admitted to our hospital from June 2015 to May 2017 were selected as experimental subjects. All patients with unstable angina were randomly divided into two groups according to the number parity method. Control group(n=54) treatment of unstable angina patients to complete the treatment of disease; observation group(54 cases): the choice of conventional therapy + metoprolol + trimetazidine treatment of unstable angina patients, and ultimately patients with unstable angina pectoris Performance, angina pectoris and treatment side effects contrast. Results Compared with the patients in the control group, the level of LVEF and the level of SV in the patients with unstable angina were significantly improved(P〈0.05). The total effective rate was 98.15% in the observation group,75.93% in the control group, and the observation group was higher than the control group(P〈0.05). There was no statistically significant difference in adverse reactions between the two groups. Conclusion The clinical choice of metoprolol + trimetazidine in patients with unstable angina pectoris can be adequately guaranteed in two aspects: improvement of cardiac function and improvement of angina pectoris, and no significant side effects of medication are observed. Thus for the recovery of patients with unstable angina improved significantly.
作者 秦子阳 Qin Ziyang(Department of Internal medicine, Shandong Province Shenxian Chinese Medicine Hospital,Liaocheng,Shandong, 252400,Chin)
出处 《当代医学》 2018年第15期40-42,共3页 Contemporary Medicine
关键词 美托洛尔 曲美他嗪 不稳定性心绞痛 临床效果 心功能效果 Metoprolol Trimetazidine Unstable angina Clinical effect Cardiac function
  • 相关文献

参考文献8

二级参考文献72

  • 1刘文铠,肖辉亮,周徐州.丹参川芎嗪注射液辅助辨治缺血性脑卒中的临床研究[J].中国生化药物杂志,2014,34(2):120-121. 被引量:14
  • 2许继艳,常秀武,丁瑞峰,张丽娟,陈锐.中西医结合治疗60例冠心病心绞痛的疗效观察[J].中国生化药物杂志,2014,34(3):111-113. 被引量:145
  • 3孙守兵,王昕,宋晓琳.益气逐瘀丸的制备及临床应用[J].河南中医,2005,25(11):70-70. 被引量:1
  • 4万大国,张强,曾秋棠.冠心病患者介入治疗前后血清VEGF水平变化及意义[J].山东医药,2007,47(2):59-60. 被引量:9
  • 5中华医学会心血管疾病学分会.不稳定性心绞痛诊断和治疗建议.中华心血管病杂志,2000,.
  • 6Tousoulis D, AntoniadesC, Katsi V, et al. The impact of early administration of low-dose atorvastatin treatment on inflammatory process, in patients with unstable angina and low cholesterol level [J]. Int J Cardiol, 2006, 109(1): 48-52.
  • 7Takenaka M, Hirade K, Tanabe K, et al. Simvastatin stimulates VEGF release via P44/P42 MAP kinase in vascular smooth muscle cells[J]. Biochem Biophys Res Commun, 2003, 301(1): 198-203.
  • 8.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002.346-348.
  • 9张惠珍.丹红治疗不稳定心绞痛疗效观察[J].社区中医药,2010,5(12):111.
  • 10Kaya EB,Ozer N,Deveci OS,et aI.The early predictors of ventricular remodeling after myocardial infarction:the role of tumor necrosis factor- alpha[J]. Anadolu Kardiyol Derg, 2009,9(2): 84-90.

共引文献110

同被引文献42

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部